Ustekinumab – March 2026

Injection 45 mg in 0.5 mL single use pre-filled syringe, Injection 90 mg in 1 mL single use pre-filled syringe

  • Brand names:
    • Ardelya®
  • Pharmaceutical Company:
    • SANDOZ PTY LTD
  • Condition/Indication: Severe chronic plaque psoriasis. Severe psoriatic arthritis.
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026